Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01584128 · ClinicalTrials.gov registry record
Oxidized Regenerated Cellulose to Decrease Vaginal Cuff Complications
A clinical trial, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- 101
- Enrollment target
NCT01584128: Completed study, sponsored by Milton S. Hershey Medical Center.
NCT01584128 is a clinical trial that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 101 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01584128 has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- 101 participants
- Enrollment target
Study Summary
The goal of the investigators study is to determine whether the use of oxidized regenerated cellulose reduces the risk of vaginal cuff cellulitis, pelvic abscess, or vaginal cuff dehiscence in patients undergoing laparoscopic hysterectomy. The investigators hypothesize that the use of oxidized regenerated cellulose will reduce the risk of vaginal cuff cellulitis, pelvic abscess, and vaginal cuff dehiscence in patients undergoing laparoscopic hysterectomy.
Primary Outcome
Incidence of vaginal cuff complicationsincluding vaginal cuff dehiscence, vaginal cuff cellulitis, and vaginal cuff abscess
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2012-04 |
| Est. Completion | 2013-03-01 |
What the finished NCT01584128 record still lists
NCT01584128 is an observational study that tracks outcomes without assigning an intervention. The registered 101 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01584128 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01584128 about?
NCT01584128 is a clinical study titled "Oxidized Regenerated Cellulose to Decrease Vaginal Cuff Complications". The goal of the investigators study is to determine whether the use of oxidized regenerated cellulose reduces the risk of vaginal cuff cellulitis, pelvic abscess, or vaginal cuff dehiscence in patients undergoing laparoscopic hysterectomy. The investigators hypothesize that the use of oxidized regen...
What is the current status of trial NCT01584128?
This trial is currently completed. The enrollment target is 101 participants. The study started on 2012-04. Estimated completion is 2013-03-01.
Who is sponsoring clinical trial NCT01584128?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04033497 · 101 participants · NA
Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
- NCT05111574 · 101 participants · Phase 2
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
- NCT05984680 · 101 participants
COPD Care Pathway Among Patients With Cancer
- NCT06266299 · 101 participants · Phase 1
A Study of KK2269 in Adult Participants With Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia